INDEX PHARM. AB AK B O.N.
InDex Pharmaceuticals Holding AB (publ) engages in the research and development of pharmaceuticals for immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.
INDEX PHARM. AB AK B O.N. (1NP) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INDEX PHARM. AB AK B O.N. (1NP) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INDEX PHARM. AB AK B O.N. - Net Assets Trend (None–None)
This chart illustrates how INDEX PHARM. AB AK B O.N.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INDEX PHARM. AB AK B O.N. (None–None)
The table below shows the annual net assets of INDEX PHARM. AB AK B O.N. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INDEX PHARM. AB AK B O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INDEX PHARM. AB AK B O.N. Competitors by Market Cap
The table below lists competitors of INDEX PHARM. AB AK B O.N. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shinsung E&G Co. Ltd
KO:011930
|
$327.80 Million |
|
tonies SE
PINK:TNIEF
|
$328.05 Million |
|
Shenzhen Silver Basis Technology Co Ltd
SHE:002786
|
$328.17 Million |
|
Sunfly Intelligent Technology Co Ltd
SHE:300423
|
$328.17 Million |
|
Gallantt Ispat Limited
NSE:GALLANTT
|
$327.71 Million |
|
Bonheur
OL:BONHR
|
$327.67 Million |
|
Beyond Meat Inc
NASDAQ:BYND
|
$327.25 Million |
|
Hunan Chen Dian International Development Co Ltd
SHG:600969
|
$327.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INDEX PHARM. AB AK B O.N.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INDEX PHARM. AB AK B O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INDEX PHARM. AB AK B O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INDEX PHARM. AB AK B O.N.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INDEX PHARM. AB AK B O.N. (1NP) | €- | N/A | N/A | $327.80 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |